Routine Stenting of Extravesical Ureteroneocystostomy in Kidney Transplantation: A Systematic Review and Meta-analysis

N. Abrol, P. G. Dean, M. Prieto, Mark D Stegall, Timucin Taner

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Although rare, major urologic complications (MUC) in kidney transplantation can cause significant morbidity, increased cost, and may even lead to graft loss. Ureteric stents are routinely used to prevent MUC, although complications related to their use have been reported. Here, we systematically reviewed the role of routine stenting in preventing MUC in kidney transplantation with extravesical ureteric implantation and performed a meta-analysis of 6 randomized controlled trials. Methods: A PubMed search was performed for studies on MUC and stents in kidney transplant recipients. Randomized controlled trials were shortlisted for the review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. RevMan 5 was used for statistical analysis, and outcome analysis was done with Cochran-Mantel-Haenszel test using random effect model. Results: Six trials meeting the criteria were identified. Although stent use did not decrease the incidence of urinary leak (odds ratio [OR], 0.39; 95% CI, 0.14–1.11; P =.08) or obstruction (OR, 0.41; 95% CI, 0.13–1.24; P =.11), it was associated with a higher incidence of urinary tract infection (OR, 3.59; 95% CI, 1.33–9.75; P =.01). Conclusion: In the present era of extravesical ureterovesical anastomosis, routine stenting has a limited role in decreasing major urologic complications and may be associated with higher incidence of urinary tract infections.

Original languageEnglish (US)
Pages (from-to)3397-3404
Number of pages8
JournalTransplantation Proceedings
Volume50
Issue number10
DOIs
StatePublished - Dec 1 2018

Fingerprint

Kidney Transplantation
Stents
Meta-Analysis
Odds Ratio
Urinary Tract Infections
Incidence
Randomized Controlled Trials
PubMed
Guidelines
Morbidity
Transplants
Kidney
Costs and Cost Analysis
Transplant Recipients

ASJC Scopus subject areas

  • Surgery
  • Transplantation

Cite this

Routine Stenting of Extravesical Ureteroneocystostomy in Kidney Transplantation : A Systematic Review and Meta-analysis. / Abrol, N.; Dean, P. G.; Prieto, M.; Stegall, Mark D; Taner, Timucin.

In: Transplantation Proceedings, Vol. 50, No. 10, 01.12.2018, p. 3397-3404.

Research output: Contribution to journalArticle

@article{2e7f3ea8811047578202789ddc60ff43,
title = "Routine Stenting of Extravesical Ureteroneocystostomy in Kidney Transplantation: A Systematic Review and Meta-analysis",
abstract = "Background: Although rare, major urologic complications (MUC) in kidney transplantation can cause significant morbidity, increased cost, and may even lead to graft loss. Ureteric stents are routinely used to prevent MUC, although complications related to their use have been reported. Here, we systematically reviewed the role of routine stenting in preventing MUC in kidney transplantation with extravesical ureteric implantation and performed a meta-analysis of 6 randomized controlled trials. Methods: A PubMed search was performed for studies on MUC and stents in kidney transplant recipients. Randomized controlled trials were shortlisted for the review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. RevMan 5 was used for statistical analysis, and outcome analysis was done with Cochran-Mantel-Haenszel test using random effect model. Results: Six trials meeting the criteria were identified. Although stent use did not decrease the incidence of urinary leak (odds ratio [OR], 0.39; 95{\%} CI, 0.14–1.11; P =.08) or obstruction (OR, 0.41; 95{\%} CI, 0.13–1.24; P =.11), it was associated with a higher incidence of urinary tract infection (OR, 3.59; 95{\%} CI, 1.33–9.75; P =.01). Conclusion: In the present era of extravesical ureterovesical anastomosis, routine stenting has a limited role in decreasing major urologic complications and may be associated with higher incidence of urinary tract infections.",
author = "N. Abrol and Dean, {P. G.} and M. Prieto and Stegall, {Mark D} and Timucin Taner",
year = "2018",
month = "12",
day = "1",
doi = "10.1016/j.transproceed.2018.06.041",
language = "English (US)",
volume = "50",
pages = "3397--3404",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "10",

}

TY - JOUR

T1 - Routine Stenting of Extravesical Ureteroneocystostomy in Kidney Transplantation

T2 - A Systematic Review and Meta-analysis

AU - Abrol, N.

AU - Dean, P. G.

AU - Prieto, M.

AU - Stegall, Mark D

AU - Taner, Timucin

PY - 2018/12/1

Y1 - 2018/12/1

N2 - Background: Although rare, major urologic complications (MUC) in kidney transplantation can cause significant morbidity, increased cost, and may even lead to graft loss. Ureteric stents are routinely used to prevent MUC, although complications related to their use have been reported. Here, we systematically reviewed the role of routine stenting in preventing MUC in kidney transplantation with extravesical ureteric implantation and performed a meta-analysis of 6 randomized controlled trials. Methods: A PubMed search was performed for studies on MUC and stents in kidney transplant recipients. Randomized controlled trials were shortlisted for the review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. RevMan 5 was used for statistical analysis, and outcome analysis was done with Cochran-Mantel-Haenszel test using random effect model. Results: Six trials meeting the criteria were identified. Although stent use did not decrease the incidence of urinary leak (odds ratio [OR], 0.39; 95% CI, 0.14–1.11; P =.08) or obstruction (OR, 0.41; 95% CI, 0.13–1.24; P =.11), it was associated with a higher incidence of urinary tract infection (OR, 3.59; 95% CI, 1.33–9.75; P =.01). Conclusion: In the present era of extravesical ureterovesical anastomosis, routine stenting has a limited role in decreasing major urologic complications and may be associated with higher incidence of urinary tract infections.

AB - Background: Although rare, major urologic complications (MUC) in kidney transplantation can cause significant morbidity, increased cost, and may even lead to graft loss. Ureteric stents are routinely used to prevent MUC, although complications related to their use have been reported. Here, we systematically reviewed the role of routine stenting in preventing MUC in kidney transplantation with extravesical ureteric implantation and performed a meta-analysis of 6 randomized controlled trials. Methods: A PubMed search was performed for studies on MUC and stents in kidney transplant recipients. Randomized controlled trials were shortlisted for the review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. RevMan 5 was used for statistical analysis, and outcome analysis was done with Cochran-Mantel-Haenszel test using random effect model. Results: Six trials meeting the criteria were identified. Although stent use did not decrease the incidence of urinary leak (odds ratio [OR], 0.39; 95% CI, 0.14–1.11; P =.08) or obstruction (OR, 0.41; 95% CI, 0.13–1.24; P =.11), it was associated with a higher incidence of urinary tract infection (OR, 3.59; 95% CI, 1.33–9.75; P =.01). Conclusion: In the present era of extravesical ureterovesical anastomosis, routine stenting has a limited role in decreasing major urologic complications and may be associated with higher incidence of urinary tract infections.

UR - http://www.scopus.com/inward/record.url?scp=85058565642&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85058565642&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2018.06.041

DO - 10.1016/j.transproceed.2018.06.041

M3 - Article

C2 - 30577212

AN - SCOPUS:85058565642

VL - 50

SP - 3397

EP - 3404

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 10

ER -